Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy

BACKGROUND: This study aimed to recognize the hub genes associated with prognosis in follicular lymphoma (FL) treated with first-line rituximab combined with chemotherapy. METHOD: RNA sequencing data of dataset GSE65135 (n = 24) were included in differentially expressed genes (DEGs) analysis. Weight...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu, Wang, Shasha, Tao, Yunxia, Chen, Haizhu, Qin, Yan, He, Xiaohui, Zhou, Shengyu, Liu, Peng, Yang, Jianliang, Yang, Sheng, Gui, Lin, Lou, Ning, Zhang, Zhishang, Yao, Jiarui, Han, Xiaohong, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454033/
https://www.ncbi.nlm.nih.gov/pubmed/34544443
http://dx.doi.org/10.1186/s12967-021-03078-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454033/
https://www.ncbi.nlm.nih.gov/pubmed/34544443
http://dx.doi.org/10.1186/s12967-021-03078-9

Ejemplares similares